n-3 FA increase liver uptake of HDL-cholesterol in mice

被引:33
|
作者
le Morvan, V [1 ]
Dumon, MF [1 ]
Palos-Pinto, A [1 ]
Bérard, AM [1 ]
机构
[1] Univ Bordeaux 2, Lab Biochim & Biol Mol, F-33076 Bordeaux, France
关键词
D O I
10.1007/s11745-002-0959-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In humans, diets rich in fish oil (containing n-3 FA) decrease the incidence of coronary artery diseases. This is thought to be caused by the induction in liver and skeletal muscle of genes involved in lipid oxidation, and to the repression in liver and adipose tissue of genes responsible for lipogenesis. n-3 FA are known to reduce the synthesis of FA and TG in the liver, resulting in a decrease of plasma concentrations of TG-rich lipoproteins. On the other hand, little is known of a possible effect of n-3 FA on HDL metabolism. To investigate this question, female C57Bl/6J mice were fed an n-3 FA-enriched diet for 16 wk. As expected from previous studies, we found that total cholesterol, TG, and phospholipids were reduced in the plasma of treated mice. We also found that HDL-cholesterol decreased after this treatment and that the in vivo fractional catabolic rate of HDL-cholesteryl ester was significantly higher in treated mice than in control mice fed a standard diet. Consistent with these results, treated mice exhibited increased uptake of HDL-cholesteryl ester in the liver. Moreover, quantitative reverse transcriptase-PCR analysis showed a two- to threefold increase in scavenger receptor B-1 gene expression. Taken together, these results suggest that an n-3 FA-enriched diet stimulates one step in the reverse cholesterol transport in mice, probably by increasing the amount of the scavenger receptor class B-1. These effects of n-3 FA on HDL metabolism may contribute to their beneficial effects on the vasculature.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 50 条
  • [21] Increase or decrease of HDL-cholesterol concentrations during pravastatin treatment depending on the pre-treatment HDL cholesterol levels
    Y. Narita
    Y. Kitazoe
    Y. Kurihara
    Y. Okuhara
    K. Takamatsu
    N. Saito
    Y. Doi
    European Journal of Clinical Pharmacology, 1997, 52 : 461 - 463
  • [22] Transient Increase in HDL-Cholesterol During Weight Gain by Hyperalimentation in Healthy Subjects
    Lindstrom, Torbjorn
    Kechagias, Stergios
    Carlsson, Martin
    Nystrom, Fredrik H.
    OBESITY, 2011, 19 (04) : 812 - 817
  • [23] Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study
    Gao, Shengqiang
    Ramen, Kuvaneshan
    Yu, Shian
    Luo, Jiansheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (10): : 2569 - 2575
  • [24] High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
    Rodriguez, Annabelle
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (01)
  • [25] High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
    Annabelle Rodriguez
    Current Atherosclerosis Reports, 2021, 23
  • [26] Sex Differences in the Methylome and Transcriptome of the Human Liver and Circulating HDL-Cholesterol Levels
    Garcia-Calzon, Sonia
    Perfilyev, Alexander
    de Mello, Vanessa D.
    Pihlajamaki, Jussi
    Ling, Charlotte
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (12): : 4395 - 4408
  • [27] Intestinal Regulation of Plasma HDL-Cholesterol Levels in Atherosclerosis-Resistant Mice
    Sontag, Timothy J.
    Reardon, Catherine A.
    Getz, Godfrey S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E72 - E72
  • [28] Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population
    Tianhui An
    Yi Song
    Yi Yang
    Mengyuan Guo
    Hui Liu
    Kun Liu
    Zhaohui Wang
    Lipids in Health and Disease, 17
  • [29] Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population
    An, Tianhui
    Song, Yi
    Yang, Yi
    Guo, Mengyuan
    Liu, Hui
    Liu, Kun
    Wang, Zhaohui
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [30] Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients
    Negredo, E
    Ribalta, J
    Ferré, R
    Salazar, J
    Rey-Joly, C
    Sirera, G
    Masana, L
    Clotet, B
    AIDS, 2004, 18 (05) : 819 - 821